nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—tongue—hypothyroidism	0.101	0.117	CbGeAlD
Tofisopam—PDE2A—adrenal cortex—hypothyroidism	0.0397	0.046	CbGeAlD
Tofisopam—PDE2A—heart—hypothyroidism	0.0384	0.0445	CbGeAlD
Tofisopam—PDE10A—heart—hypothyroidism	0.0384	0.0445	CbGeAlD
Tofisopam—PDE2A—cardiovascular system—hypothyroidism	0.0362	0.0419	CbGeAlD
Tofisopam—PDE2A—pituitary gland—hypothyroidism	0.0321	0.0371	CbGeAlD
Tofisopam—PDE2A—adrenal gland—hypothyroidism	0.0287	0.0332	CbGeAlD
Tofisopam—PDE10A—adrenal gland—hypothyroidism	0.0287	0.0332	CbGeAlD
Tofisopam—PDE2A—blood—hypothyroidism	0.0287	0.0332	CbGeAlD
Tofisopam—PDE2A—thyroid gland—hypothyroidism	0.0277	0.032	CbGeAlD
Tofisopam—PDE10A—thyroid gland—hypothyroidism	0.0277	0.032	CbGeAlD
Tofisopam—CYP3A4—urine—hypothyroidism	0.0273	0.0316	CbGeAlD
Tofisopam—PDE10A—female gonad—hypothyroidism	0.0267	0.0309	CbGeAlD
Tofisopam—PDE4A—heart—hypothyroidism	0.0264	0.0306	CbGeAlD
Tofisopam—PDE2A—testis—hypothyroidism	0.0237	0.0274	CbGeAlD
Tofisopam—PDE10A—testis—hypothyroidism	0.0237	0.0274	CbGeAlD
Tofisopam—PDE2A—liver—hypothyroidism	0.0224	0.0259	CbGeAlD
Tofisopam—PDE10A—cerebellum—hypothyroidism	0.0219	0.0253	CbGeAlD
Tofisopam—PDE2A—cerebellum—hypothyroidism	0.0219	0.0253	CbGeAlD
Tofisopam—PDE3A—heart—hypothyroidism	0.0219	0.0253	CbGeAlD
Tofisopam—PDE3A—cardiovascular system—hypothyroidism	0.0206	0.0239	CbGeAlD
Tofisopam—PDE4A—adrenal gland—hypothyroidism	0.0197	0.0228	CbGeAlD
Tofisopam—PDE4A—thyroid gland—hypothyroidism	0.019	0.022	CbGeAlD
Tofisopam—PDE4A—female gonad—hypothyroidism	0.0184	0.0213	CbGeAlD
Tofisopam—PDE3A—adrenal gland—hypothyroidism	0.0163	0.0189	CbGeAlD
Tofisopam—PDE4A—testis—hypothyroidism	0.0163	0.0189	CbGeAlD
Tofisopam—PDE3A—blood—hypothyroidism	0.0163	0.0189	CbGeAlD
Tofisopam—PDE3A—thyroid gland—hypothyroidism	0.0157	0.0182	CbGeAlD
Tofisopam—PDE3A—female gonad—hypothyroidism	0.0152	0.0176	CbGeAlD
Tofisopam—PDE4A—cerebellum—hypothyroidism	0.0151	0.0174	CbGeAlD
Tofisopam—PDE3A—testis—hypothyroidism	0.0135	0.0156	CbGeAlD
Tofisopam—PDE3A—liver—hypothyroidism	0.0128	0.0148	CbGeAlD
Tofisopam—PDE3A—cerebellum—hypothyroidism	0.0125	0.0144	CbGeAlD
Tofisopam—PDE2A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00801	0.0589	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00801	0.0589	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00607	0.0446	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00607	0.0446	CbGpPWpGaD
Tofisopam—CYP3A4—blood—hypothyroidism	0.00523	0.00605	CbGeAlD
Tofisopam—PDE2A—G alpha (s) signalling events—AVP—hypothyroidism	0.00472	0.0347	CbGpPWpGaD
Tofisopam—CYP3A4—liver—hypothyroidism	0.00409	0.00473	CbGeAlD
Tofisopam—PDE4A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00368	0.027	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00368	0.027	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—AVP—hypothyroidism	0.00358	0.0263	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00358	0.0263	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00358	0.0263	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—POMC—hypothyroidism	0.00314	0.0231	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—POMC—hypothyroidism	0.00238	0.0175	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—SH2B3—hypothyroidism	0.00232	0.017	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—AVP—hypothyroidism	0.00217	0.0159	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—AVP—hypothyroidism	0.00211	0.0155	CbGpPWpGaD
Tofisopam—PDE4A—Opioid Signalling—POMC—hypothyroidism	0.00202	0.0149	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—TRH—hypothyroidism	0.00184	0.0135	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—SH2B3—hypothyroidism	0.00176	0.0129	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TRH—hypothyroidism	0.00167	0.0123	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—TSHB—hypothyroidism	0.00164	0.0121	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—TSHR—hypothyroidism	0.00164	0.0121	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—VAV3—hypothyroidism	0.00159	0.0117	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TSHB—hypothyroidism	0.00149	0.011	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TSHR—hypothyroidism	0.00149	0.011	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—POMC—hypothyroidism	0.00144	0.0106	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—POMC—hypothyroidism	0.0014	0.0103	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—TRH—hypothyroidism	0.0014	0.0103	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TRH—hypothyroidism	0.00127	0.00932	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—TSHB—hypothyroidism	0.00125	0.00915	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—TSHR—hypothyroidism	0.00125	0.00915	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—VAV3—hypothyroidism	0.00121	0.00886	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CLTC—hypothyroidism	0.00114	0.00841	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TSHR—hypothyroidism	0.00113	0.00831	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TSHB—hypothyroidism	0.00113	0.00831	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—SH2B3—hypothyroidism	0.00103	0.00761	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—VAV3—hypothyroidism	0.001	0.00739	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TRH—hypothyroidism	0.000989	0.00727	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IGF1—hypothyroidism	0.000979	0.0072	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AVP—hypothyroidism	0.000968	0.00712	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—VAV3—hypothyroidism	0.000913	0.00671	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TSHB—hypothyroidism	0.000881	0.00648	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TSHR—hypothyroidism	0.000881	0.00648	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AVP—hypothyroidism	0.000879	0.00646	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CLTC—hypothyroidism	0.000867	0.00637	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—TRH—hypothyroidism	0.000846	0.00622	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—TRH—hypothyroidism	0.000823	0.00605	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SH2B3—hypothyroidism	0.000785	0.00577	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TRH—hypothyroidism	0.000769	0.00565	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—VAV3—hypothyroidism	0.000762	0.0056	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—TSHR—hypothyroidism	0.000754	0.00554	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—TSHB—hypothyroidism	0.000754	0.00554	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TRH—hypothyroidism	0.000749	0.00551	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TRH—hypothyroidism	0.000748	0.0055	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IGF1—hypothyroidism	0.000742	0.00546	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—TSHB—hypothyroidism	0.000734	0.00539	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AVP—hypothyroidism	0.000734	0.00539	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—TSHR—hypothyroidism	0.000734	0.00539	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VAV3—hypothyroidism	0.00071	0.00522	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—VAV3—hypothyroidism	0.000692	0.00508	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TSHB—hypothyroidism	0.000685	0.00504	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TSHR—hypothyroidism	0.000685	0.00504	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TSHB—hypothyroidism	0.000668	0.00491	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TSHR—hypothyroidism	0.000668	0.00491	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TSHB—hypothyroidism	0.000666	0.0049	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TSHR—hypothyroidism	0.000666	0.0049	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AVP—hypothyroidism	0.000666	0.0049	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—POMC—hypothyroidism	0.000643	0.00473	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SH2B3—hypothyroidism	0.000595	0.00438	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—POMC—hypothyroidism	0.000584	0.0043	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PRL—hypothyroidism	0.000583	0.00428	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—VAV3—hypothyroidism	0.000539	0.00396	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CLTC—hypothyroidism	0.000525	0.00386	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AVP—hypothyroidism	0.000519	0.00382	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CLTC—hypothyroidism	0.000511	0.00376	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—POMC—hypothyroidism	0.000488	0.00358	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—VAV3—hypothyroidism	0.000461	0.00339	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TRH—hypothyroidism	0.000454	0.00334	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—VAV3—hypothyroidism	0.000449	0.0033	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AVP—hypothyroidism	0.000445	0.00327	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—POMC—hypothyroidism	0.000443	0.00326	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PRL—hypothyroidism	0.000442	0.00325	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TRH—hypothyroidism	0.000442	0.00325	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IGF1—hypothyroidism	0.000437	0.00322	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AVP—hypothyroidism	0.000432	0.00318	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—VAV3—hypothyroidism	0.000419	0.00308	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VAV3—hypothyroidism	0.000409	0.003	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—VAV3—hypothyroidism	0.000408	0.003	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TSHR—hypothyroidism	0.000405	0.00297	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TSHB—hypothyroidism	0.000405	0.00297	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AVP—hypothyroidism	0.000404	0.00297	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000399	0.00293	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TSHB—hypothyroidism	0.000394	0.00289	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TSHR—hypothyroidism	0.000394	0.00289	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AVP—hypothyroidism	0.000394	0.00289	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AVP—hypothyroidism	0.000393	0.00289	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SH2B3—hypothyroidism	0.000361	0.00265	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SH2B3—hypothyroidism	0.000351	0.00258	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—POMC—hypothyroidism	0.000345	0.00254	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF1—hypothyroidism	0.000332	0.00244	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000323	0.00238	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—POMC—hypothyroidism	0.000295	0.00217	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—POMC—hypothyroidism	0.000287	0.00211	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—POMC—hypothyroidism	0.000268	0.00197	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PRL—hypothyroidism	0.000268	0.00197	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—POMC—hypothyroidism	0.000262	0.00192	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—POMC—hypothyroidism	0.000261	0.00192	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRL—hypothyroidism	0.00026	0.00191	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF1—hypothyroidism	0.000252	0.00185	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VAV3—hypothyroidism	0.000248	0.00182	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VAV3—hypothyroidism	0.000241	0.00177	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AVP—hypothyroidism	0.000238	0.00175	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AVP—hypothyroidism	0.000232	0.00171	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—IYD—hypothyroidism	0.000202	0.00149	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000172	0.00127	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000172	0.00126	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TPO—hypothyroidism	0.000162	0.00119	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—POMC—hypothyroidism	0.000158	0.00116	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—POMC—hypothyroidism	0.000154	0.00113	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF1—hypothyroidism	0.000152	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF1—hypothyroidism	0.000148	0.00109	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TSHB—hypothyroidism	7.49e-05	0.000551	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	6.68e-05	0.000491	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A5—hypothyroidism	5.61e-05	0.000412	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—POMC—hypothyroidism	2.94e-05	0.000216	CbGpPWpGaD
